White light increases anticancer effectiveness of iridium(III) complexes toward lung cancer A549 cells.
Autor: | Li G; School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, PR China., Chen J; School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, PR China., Xie Y; School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, PR China., Yang Y; Department of Pharmacy, Guangdong Second Provincial General Hospital, 510317, PR China. Electronic address: yany@gd2h.org.cn., Niu Y; School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, PR China., Chen X; School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, PR China., Zeng X; School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, PR China., Zhou L; School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, PR China., Liu Y; School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, PR China. Electronic address: lyjche@gdpu.edu.cn. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of inorganic biochemistry [J Inorg Biochem] 2024 Oct; Vol. 259, pp. 112652. Date of Electronic Publication: 2024 Jun 26. |
DOI: | 10.1016/j.jinorgbio.2024.112652 |
Abstrakt: | Anticancer activity has been extensively studies. In this article, three ligands 2-(6-bromobenzo[d][1,3]dioxol-5-yl)-1H-imidazo[4,5-f][1,10]phenanthroline (BDIP), 2-(7-methoxybenzo[d][1,3]dioxol-5-yl)-1H-imidazo[4,5-f][1,10]phenanthroline (MDIP), 2-(6-nitrobenzo[d][1,3]dioxol-5-yl)-1H-imidazo[4,5-f][1,10]phenanthroline (NDIP) and their iridium(III) complexes: [Ir(ppy) Competing Interests: Declaration of competing interest The authors declare no competing interest exists. (Copyright © 2024 Elsevier Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |